百济神州：港股公告：百济神州有限公司截至2023年6月30日止三个月及六个月未经审核业绩以及业务进展最新情况
BeiGene, Ltd.
06160
2023630
13.09
571XIVA
2023630
2023630
2023
202382
20238312023630
1995(Private Securities LitigationReform Act of 1995)悅
?
BTK
2023
10-Q
202382
Margaret Han DuganDonald W. GlazerMichael GollerAnthony C. HooperRanjeev KrishanaThomasMalleyAlessandro RivaCorazon (Corsee) D. Sanders
2023?
?
5.54
82%?
?
3.08139%46%?
(CLL)BTK?
BGNE06160688235
2023
(John V. Oyler)
??
CLL?(R/R)CLL
?
BTK
? (EMA)(CHMP)
?
(ESCC)? (FDA)
?
(sNDA)
?
R/R(FL)FDA2024
?
?
CLL(TGA)
?
(TN)R/R CLL(SLL)?
?
(NMPA)sNDATN CLL/SLL(WM)
R/R CLL/SLLR/RWM?
http://ir.beigene.com; https://hkexir.beigene.com; https://sseir.beigene.com?
(ADC)
ADC? Max29
?
CLLMax
2023
20236305.537
81.8%20223.045? 20232.492
??
? 2023
?
2.235
152.9%CLL/SLLFDA
?4,85032.2%
BTK
? 2023
?
1.495
42.5%
?
PD-1
?
6306302023202220232022
$$$$293,919212,429540,828403,164223,54088,381362,307156,269
36,2863,70160,9016,651553,745304,511964,036566,084202382.7%
76.6%
??
?
20236308.1820227.09815.2%
81.8%
20236303.811
0.28(ADS)3.642022
5.6570.42ADS5.5020236,38020221.296
20236303520221231452023
202310-Q
?
?
CLL/SLL?
TNR/R CLL/SLL? NMPA
o
TN CLL/SLLo
TN WMo
R/R CLL/SLLo
R/R WM?
? EMA CHMP
?ESCC? NMPA
o
PD-L1o ESCC
?
? NMPA?
? R/R FLsNDA
FDA
? R/R FL
(MAA)EMA
?
? 3
?
?
*
ESCC
?
?
(ES-SCLC)?
ESCC??
ESCC
?
?
??
R/RCLL3ALPINE?
?
(NSCLC)3RATIONALE-315Sonrotoclax BCL-2 BGB-11417
? 2023
?
CLL? 2023R/R
WM? 1BTK CDAC (BGB-16673)
? B1
TIGIT
? 2023NSCLC
3AdvanTIG-302? 2
o PD-
(L)1ESCCo (HCC)o NSCLC*PDUFA
? 92023
?
3RATIONALE-312? 10(ESMO)8
?
? (ASCO)(EHA)
?
R/RB(DLBCL)1?
R/R FL3ROSEWOOD
? ASCO
?
3RATIONALE 301(HCC)? ASCOOX40BGB-A4451
?
? ZymeworksASCOzanidatamab
HER22bHERIZON-BTC
?
7100
9.3
2024? 64,000
(ADC)2024?
55.95.2
62023
2024
? TIGIT
?
?
202320226301231
$ 3,527,267$ 4,540,288
299,282173,168321,333282,3461,031,938845,9465,728,7366,379,290
266,975294,781454,950467,352183,310255,887271,291293,960628,478538,1171,930,1771,995,935$ 3,798,559$ 4,383,355
ADSADS
63063020232022
20232022
$ 553,745$ 304,511$ 964,036$ 566,084
41,51637,06179,02682,114595,261341,5721,043,062648,19895,99071,173177,779136,410422,764378,207831,348768,122395,034331,403723,533625,976188188375376913,976780,9711,733,0351,530,884(318,715)(439,399)(689,973)(882,686)
15,07011,43131,08621,502(63,818)(129,617)(45,515)(117,650)(367,463)(557,585)(704,402)(978,834)
13,6748,14125,16622,090(381,137)(565,726)(729,568)(1,000,924)
$ (0.28)$ (0.42)$ (0.54)$ (0.75)1,360,224,3771,336,463,0261,357,211,3081,334,252,648ADS
$ (3.64)$ (5.50)$ (6.99)$ (9.75)ADS
104,632,644102,804,848104,400,870102,634,819
2022202363010-Q1.
2.
10,000 www.beigene.com.cn
1995(Private Securities LitigationReform Act of 1995)
?
BTK2023
10-Q
(+86 10)5895-8058(+86 10)6844-5311ir@beigene.commedia@beigene.com
?
(Genentech, Inc.)
??Pharmacyclics LLC